CANTON BIOLOGICS
Live / Registered — Registered (as of 15 Sept 2020)
What this means for you
Registered since 15 Sept 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88513445
- Registration number
- 6154612
- Mark type
- Stylized text
- Filed
- 14 Jul 2019
- Published for opposition
- 31 Dec 2019
- Registered
- 15 Sept 2020
- Attorney of record
- Yue (Robert) Xu
Goods and services
- Class 001 — Chemicals: Proteins for use in the manufacture of food supplements; proteins for the food industry; protein for use in the manufacture of cosmetics; protein in raw material form for scientific and medical research; protein for industrial use; animal albumen for use in the manufacture of skin care product; animal albumen as a raw material for industrial use; diagnostic preparations other than for medical or veterinary purposes; biological preparations for use in industry and science; biological preparation for use in cell cultures other than for medical or veterinary use; cultures of microorganisms, other than for medical and veterinary use; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; biological tissue cultures, other than for medical or veterinary purposes; biochemical catalysts; stem cells, other than for medical or veterinary purposes
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-inflammatories, anti-virals, anti-infectives, immunosuppressants and pharmaceutical antibodies; pharmaceuticals, namely, preparations for antibody and antibody-derivative development; pharmaceuticals, namely, antibodies and proteins for the treatment of oncological and autoimmune diseases and disorders; cytokine preparations and antibodies in the nature of pharmaceutical preparations for the treatment of oncological and autoimmune diseases and disorders; pharmaceutical preparations, namely, immuno- therapeutics and cytokines for the treatment of oncological and autoimmune diseases and disorders; diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; medicines for the treatment of gastrointestinal diseases, for human purposes; pharmaceutical products for the prevention and treatment of cancer, for human purposes; tumor suppressing agents, for human purpose; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for peripheral nervous system; vaccines; diagnostic preparations for medical purposes; chemical preparations for medical purposes, namely, for treating cancer; nutritional supplements; biocides; surgical glues
- Class 042 — Scientific and technological services: Biological research; medical and scientific research, namely, conducting clinical trials for others; research and development services in the field of antibodies; biotechnology research; testing of pharmaceuticals; analysis of the mode of action of chemical combinations on animals; bacteriological research; scientific laboratory services; scientific research; biomedical research services
Owner
- CANTONBIO CO., LTD., GUANGZHOU CITY, GUANGDONG PROVINCE,, CN
- CantonBio AG, 3011 Bern, CH
- CantonBio AG, 3011 Bern, CH
- CantonBio AG, 3011 Bern, CH
Prosecution history
- 15 Sept 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 03 May 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 15 Sept 2020 — REGISTERED-PRINCIPAL REGISTER
- 14 Aug 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Aug 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Jul 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Jul 2020 — USE AMENDMENT FILED
- 24 Jul 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 Jul 2020 — TEAS STATEMENT OF USE RECEIVED
- 25 Feb 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 31 Dec 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Dec 2019 — PUBLISHED FOR OPPOSITION
- 11 Dec 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Nov 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Nov 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED